Defining Spectral Quality in Mass Spectrometry‐Based Proteomics: A Retrospective Review
Mass Spectrometry Reviews · 2026-09 · 45 (5) · 914-928
DOI: 10.1002/mas.21933 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Mass Spectrometry Reviews, online erschienen am 18.04.2025. Verfasst von Vilenne Frédérique und 3 weiteren Autor:innen. Beteiligte Einrichtung: Data Science Institute, Hasselt University, Diepenbeek, Limburg, Belgium. Hauptthemen laut MEDLINE: Proteomics, Mass Spectrometry. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: This study was funded by the Research Foundation - Flanders (FWO) under the "Beyond the Genome: Ethical Aspects of Large Cohort Studies" project (Case number G…, Fonds Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
Mass spectrometry‐based proteomics is essential for advancing preventive and personalised medicine. Technological advancements have greatly increased both the number and sensitivity of spectra generated in a single experiment. Traditionally, spectra are identified using database search engines that depend on large and continuously expanding databases. This expansion enlarges the search space, posing challenges for controlling the false discovery rate in peptide identification. While many bioinformatic workflows employ rescoring algorithms as a post‐processing step to manage false discoveries, preprocessing spectra offers a promising alternative. One such method, spectral quality assessment, classifies spectra as “high” quality (likely containing a peptide) or “low” quality (predominantly consisting of noise). This review provides a comprehensive perspective on spectral quality assessment, examining existing tools and their underlying principles. We discuss key considerations such as the definition of spectral quality, normalisation, the use of experimental training data, and future research in the field. By highlighting the potential of spectral quality assessment to improve peptide identification and reduce false discoveries, we aim to elaborate on its potential for the proteomics community.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Data Science Institute, Hasselt University, Diepenbeek, Limburg, Belgium.
- Health Unit, Flemish Institute for Technological Research (VITO), Mol, Antwerpen, Belgium.
- Biomedical Hosting LLC, Arlington, Massachusetts, USA.
Förderung
- This study was funded by the Research Foundation - Flanders (FWO) under the "Beyond the Genome: Ethical Aspects of Large Cohort Studies" project (Case number G…
- Fonds Wetenschappelijk Onderzoek
Zitieren
APA
Frédérique, V., Simon, A., Manor, A., & Dirk, V. (2026). Defining Spectral Quality in Mass Spectrometry‐Based Proteomics: A Retrospective Review. Mass Spectrometry Reviews, 45(5), 914-928. https://doi.org/10.1002/mas.21933
Vancouver
Frédérique V, Simon A, Manor A, Dirk V. Defining Spectral Quality in Mass Spectrometry‐Based Proteomics: A Retrospective Review. Mass Spectrometry Reviews. 2026;45(5):914-928. doi:10.1002/mas.21933
BibTeX
@article{Frdrique2026,
author = {Frédérique, Vilenne and Simon, Appeltans and Manor, Askenazi and Dirk, Valkenborg},
title = {Defining Spectral Quality in Mass Spectrometry‐Based Proteomics: A Retrospective Review},
journal = {Mass Spectrometry Reviews},
year = {2026},
volume = {45},
number = {5},
pages = {914--928},
doi = {10.1002/mas.21933}
}
EUVIMED